The prevalence of asthma in Italy is estimated to be around 4%; it affects approximately 2,000,000 citizens, and up to 80-90% of patients have mild-to-moderate asthma. Despite the clinical relevance of mild-to-moderate asthma, longitudinal observational data are very limited, including data on disease progression (worsening vs. improvement), the response to treatment, and prognosis. Studies are needed to develop long-term, observational, real-life research in large cohorts. The primary outcomes of this study will be based on prospective observation and the epidemiological evolution of mild and moderate asthma. Secondary outcomes will include patient-reported outcomes, treatments over time, disease-related functional and inflammatory patterns, and environmental and life-style influences.
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study / Braido, Fulvio; Blasi, Francesco; Canonica, Giorgio Walter; Paggiaro, Pierluigi; Beghè, Bianca; Bonini, Matteo; Carpagnano, Giovanna Elisiana; Del Giacco, Stefano; Lavorini, Federico; Milanese, Manlio; Patella, Vincenzo; Santus, Pierachille; Contoli, Marco. - In: THE JOURNAL OF ASTHMA. - ISSN 0277-0903. - ELETTRONICO. - (2021), pp. 1-6-6. [10.1080/02770903.2021.1968895]
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study
Lavorini, FedericoMembro del Collaboration Group
;
2021
Abstract
The prevalence of asthma in Italy is estimated to be around 4%; it affects approximately 2,000,000 citizens, and up to 80-90% of patients have mild-to-moderate asthma. Despite the clinical relevance of mild-to-moderate asthma, longitudinal observational data are very limited, including data on disease progression (worsening vs. improvement), the response to treatment, and prognosis. Studies are needed to develop long-term, observational, real-life research in large cohorts. The primary outcomes of this study will be based on prospective observation and the epidemiological evolution of mild and moderate asthma. Secondary outcomes will include patient-reported outcomes, treatments over time, disease-related functional and inflammatory patterns, and environmental and life-style influences.File | Dimensione | Formato | |
---|---|---|---|
mani paper 2021.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.73 MB
Formato
Adobe PDF
|
1.73 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.